PharmaShots Connects Brands & Decision-Makers with Custom Media Solutions PharmaShots Provides Curated News & Insights for the Biopharma & Healthcare Industry PharmaShots is Empowering Decision Makers with Actionable Insights Amplify Your Brand with PharmaShots’ Expert Content Creation & Marketing Solutions PharmaShots Enables Brands to Strategically Connect with Their Target Audiences Deliver Your News to the Right Audience with PharmaShots Newswire CXO TALKS CXO TALKSRethinking Angina Treatment: Jed Litwiniuk and Uwe Tigör on Auxilius Pharma’s AUX001 | PharmaShots CXO Talks CXO TALKSCytek Biosciences on Redefining Flow Cytometry Excellence | PharmaShots CXO Talks CXO TALKSCXO Talks Podcast | Building Smarter Biotech: Venkat Nelabhotla, CEO of Vyome Holdings, on Driving Innovation Across the US–India Corridor CXO TALKSCXO Talks Podcast | The Road to Acquisition: Oncolytics’ CEO Jared Kelly on Clinical Data, IP & Pharma Partnerships EXCLUSIVE INTERVIEW EXCLUSIVEOncolytics Biotech’s Next Chapter: Jared Kelly on Advancing Pelareorep Toward Approval EXCLUSIVEGona Aziz at HLTH Europe 2026 on the Convergence of AI & 5T MRI: United Imaging’s Strategy for Advancing Precision Healthcare EXCLUSIVEExclusive: A Stimulating Dialogue with Edmund Ben Ami, Co-Founder & CEO of NeuraLight EXCLUSIVEExclusive: Dr. Mónica Domínguez from Smile Train in a Stimulating Conversation with PharmaShots on Why a Healthy Mouth is a Happy Mind EXCLUSIVEExclusive: Kenneth Sake from Blueprint Medicines in an Enlightening Conversation with PharmaShots EXCLUSIVEExclusive Coverage: Dr. Ikshit Sharma from AIMIL Pharmaceuticals in a Stimulating Dialogue Exchange with PharmaShots EXCLUSIVEAdvancing Care for Hematologic Malignancies: Chris Heery from Arcellx in a Stimulating Dialogue Exchange with PharmaShots EXCLUSIVEDecoding Approval: Moitreyee Chatterjee-Kishore from Astellas in an Exclusive Conversation with PharmaShots LATEST NEWSStay up-to-date Oncolytics Biotech Reports GOBLET Study Results Timeline and PanCAN Grant Milestone 6 hours ago Nxera Pharma Partners with Synmosa to Commercialize Quviviq Across Eight Asia-Pacific Markets 9 hours ago Galderma to Acquire ZO Skin Health for $1.5B 10 hours ago Prelude Therapeutics and Lilly Collaborate to Evaluate PRT13722 Combinations in HR+/HER2- Breast Cancer 11 hours ago Rhythm Pharmaceuticals Launches IMCIVREE in Japan for Acquired Hypothalamic Obesity 13 hours ago Generate Biomedicines and Zealand Pharma Enter ~$1.2B AI-Driven Metabolic Disease Collaboration 14 hours ago Read More Your Daily Dose of Biopharma News & Insights Delivered to Your Inbox. Join the PharmaShots Family of 20000+ subscribers Subscribe Now
Nxera Pharma Partners with Synmosa to Commercialize Quviviq Across Eight Asia-Pacific Markets 9 hours ago
Prelude Therapeutics and Lilly Collaborate to Evaluate PRT13722 Combinations in HR+/HER2- Breast Cancer 11 hours ago
Generate Biomedicines and Zealand Pharma Enter ~$1.2B AI-Driven Metabolic Disease Collaboration 14 hours ago
